David Goel Matrix Capital Management Company
David Goel is a co-founder of Matrix Capital Management, a technology-oriented investment firm with public and private market activities. Matrix is known for concentrated positions in software, semiconductor, and internet-related businesses. Goel’s filings are monitored for high-conviction technology themes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CMRC
Commerce.com Inc Series 1
CMRC
|
+$87.8M |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$57.4M |
| 3 |
Castle Biosciences
CSTL
|
+$54.2M |
| 4 |
ALTR
Altair Engineering Inc
ALTR
|
+$51.4M |
| 5 |
C3.ai
AI
|
+$40.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LVGO
Livongo Health, Inc. Common Stock
LVGO
|
+$108M |
| 2 |
Cloudflare
NET
|
+$20.7M |
| 3 |
JAMF
Jamf
JAMF
|
+$5.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 50.64% |
| 2 | Communication Services | 19.93% |
| 3 | Healthcare | 14.55% |
| 4 | Industrials | 13.07% |
| 5 | Consumer Discretionary | 1.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Netflix
NFLX
$331B
| $1.08B | 11.7% |
20,000,000
| – | – |
|
2
Adaptive Biotechnologies
ADPT
$4.15B
| $775M | 8.39% |
13,115,090
| – | – |
|
3
Walt Disney
DIS
$186B
| $761M | 8.23% |
4,200,000
| – | – |
|
4
TransDigm Group
TDG
$66.4B
| $678M | 7.33% |
1,094,900
| – | – |
|
5
CrowdStrike
CRWD
$195B
| $635M | 6.87% |
12,000,000
| – | – |
|
6
Micron Technology
MU
$1.09T
| $600M | 6.49% |
7,985,000
| – | – |
|
7
Salesforce
CRM
$171B
| $584M | 6.31% |
2,622,309
| – | – |
|
8
Global Payments
GPN
$24.7B
| $530M | 5.74% |
2,462,588
| – | – |
|
9
Qualcomm
QCOM
$169B
| $508M | 5.5% |
3,337,360
| – | – |
|
|
NEWR
10
DELISTED
New Relic, Inc.
NEWR
| $327M | 3.54% |
5,000,000
| – | – |
|
|
ALTR
11
DELISTED
Altair Engineering Inc
ALTR
| $300M | 3.24% |
5,155,025
+1,018,300
| +25% | +$51.4M |
|
|
DOCU
12
DocuSign
DOCU
$11.8B
| $299M | 3.23% |
1,345,166
| – | – |
|
|
XLNX
13
DELISTED
Xilinx Inc
XLNX
| $298M | 3.22% |
2,100,000
| – | – |
|
14
Applied Materials
AMAT
$391B
| $260M | 2.81% |
3,013,000
+250,000
| +9% | +$18.5M |
|
15
Workday
WDAY
$49.4B
| $253M | 2.74% |
1,056,043
| – | – |
|
|
CMRC
16
Commerce.com Inc Series 1
CMRC
$184M
| $218M | 2.36% |
3,403,708
+1,100,000
| +48% | +$87.8M |
|
|
ADAP
17
DELISTED
Adaptimmune Therapeutics
ADAP
| $210M | 2.27% |
38,974,185
| – | – |
|
18
Zentalis Pharmaceuticals
ZNTL
$363M
| $199M | 2.15% |
3,821,739
| – | – |
|
19
Amazon
AMZN
$2.79T
| $168M | 1.81% |
1,030,000
| – | – |
|
20
Dynatrace
DT
$14.2B
| $108M | 1.17% |
2,500,000
+871,200
| +53% | +$34.6M |
|
21
Unity
U
$20.7B
| $76.7M | 0.83% |
500,000
| – | – |
|
22
Lam Research
LRCX
$393B
| $70.8M | 0.77% |
1,500,000
+500,000
| +50% | +$21M |
|
|
23
Castle Biosciences
CSTL
$1.04B
| $67.2M | 0.73% |
+1,000,000
| New | +$54.2M |
|
|
SILK
24
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $53.4M | 0.58% |
847,134
+7,134
| +0.8% | +$443K |
|
25
Guidewire Software
GWRE
$15.8B
| $51.5M | 0.56% |
400,000
| – | – |
|
Similar funds
David Goel's Q4 2020 Portfolio in Review
As of Q4 2020, David Goel held 33 positions worth $9.25B, up 23% from $7.52B the previous quarter. Its ten largest holdings account for 70% of the portfolio.
David Goel's Q4 2020 filing shows 4 new, 6 increased and 4 closed positions. Its largest new stake was Splunk Inc: 300,000 shares worth $51M. The largest sale was Livongo Health, Inc. Common Stock, an estimated $108M.
By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 48% a quarter earlier, followed by Communication Services and Healthcare.
- David Goel's largest Q4 2020 buy was Splunk Inc: 300,000 shares worth $51M.
- David Goel added most to Commerce.com Inc Series 1 in Q4 2020, an estimated $87.8M increase.
- David Goel fully exited Livongo Health, Inc. Common Stock in Q4 2020, selling an estimated $108M.
- David Goel's ten largest holdings make up 70% of its $9.25B portfolio in Q4 2020.
- David Goel opened 4 new positions and closed 4 in Q4 2020.
- David Goel's portfolio value rose 23% quarter-over-quarter to $9.25B.
Based on Matrix Capital Management Company's 13F filing for Q4 2020, filed 16 Feb 2021.